Related Experiment Video

Updated: Aug 12, 2026

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
06:58

Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

Published on: June 25, 2016

[Carbamazepine dosage and its blood serum level in children]

J Czochańska, Z Losiowski, J Prokopczyk

    Neurologia I Neurochirurgia Polska
    |January 1, 1987
    PubMed

    Insights

    This study found no simple correlation between carbamazepine dosage and plasma levels in children. However, doses over 25 mg/kg daily increased carbamazepine plasma levels, suggesting a potential therapeutic range.

    Area of Science:

    • Pediatric Pharmacology
    • Clinical Pharmacy
    • Neuropharmacology

    Background:

    • Carbamazepine is a widely used antiepileptic drug.
    • Determining optimal carbamazepine dosage in children is challenging due to variable pharmacokinetics.
    • Understanding dose-plasma level relationships is crucial for effective treatment and minimizing toxicity.

    Purpose of the Study:

    • To evaluate the correlation between carbamazepine dosage and plasma levels in pediatric patients.
    • To identify potential dose thresholds influencing carbamazepine plasma concentrations in children.

    Main Methods:

    • A cohort of 62 children (4 months to 14 years) receiving carbamazepine was studied.
    • Carbamazepine dosage and plasma levels were analyzed.
    • Data were assessed for correlations between dose and therapeutic levels.

    Main Results:

    • No simple correlation was found between carbamazepine dosage and plasma levels across all children.
    • Most children receiving appropriate doses achieved therapeutic plasma carbamazepine levels.
    • Carbamazepine doses exceeding 25 mg/kg/day were associated with further increases in plasma levels.

    Conclusions:

    • A straightforward dose-response relationship for carbamazepine in children could not be established.
    • Therapeutic plasma levels are achievable with appropriate dosing in most pediatric patients.
    • Dosages above 25 mg/kg/day may lead to higher carbamazepine plasma concentrations, warranting careful monitoring.

    More Related Videos

    Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy10:22

    Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

    Published on: December 6, 2016

    Sampling Cerebrospinal Fluid and Blood from Lateral Tail Vein in Rats During EEG Recordings10:46

    Sampling Cerebrospinal Fluid and Blood from Lateral Tail Vein in Rats During EEG Recordings

    Published on: September 1, 2023

    Related Concept Videos

    Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

    Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

    Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
    SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...